Human mesenchymal stem cells improve ex vivo expansion of adult human CD34+ peripheral blood progenitor cells and decrease their allostimulatory capacity
- 1 March 2007
- journal article
- Published by Elsevier BV in Experimental Hematology
- Vol. 35 (3), 507-515
- https://doi.org/10.1016/j.exphem.2006.10.015
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Tumor Cell Purging by Ex Vivo Expansion of Hemopoietic Stem Cells from Breast Cancer Patients Combined with Targeting ErbB ReceptorsTransplantation and Cellular Therapy, 2006
- Role for Interferon-γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem CellsThe International Journal of Cell Cloning, 2005
- A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cellsExperimental Hematology, 2005
- Improved haematopoietic recovery following transplantation with ex vivo‐expanded mobilized blood cells*British Journal of Haematology, 2004
- Cell‐Cell Contact and Anatomical Compatibility in Stromal Cell‐Mediated HSC Support During DevelopmentThe International Journal of Cell Cloning, 2004
- Ex vivo culture rescues hematopoietic stem cells with long-term repopulating capacity following harvest from lethally irradiated miceExperimental Hematology, 2004
- Autologous tandem transplantation: almost complete reduction of neutropenic fever following the second transplantation by ex vivo expanded autologous myeloid postprogenitor cellsBone Marrow Transplantation, 2003
- Expansion of LTC‐ICs and Maintenance of p21 and BCL‐2 Expression in Cord Blood CD34 + /CD38 − Early Progenitors Cultured over Human MSCs as a Feeder LayerThe International Journal of Cell Cloning, 2002
- Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptorJCI Insight, 2000
- Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cellsThe Lancet, 1999